UK Study of tendo Achilles Rehabilitation

Conditions

Achilles tendon rupture Injury, Occupational Diseases, Poisoning

Costa ML, Achten J, Marian IR, Dutton SJ, Lamb SE, Ollivere B, Maredza M, Petrou S, Kearney RS, UKSTAR trial collaborators.

2020-02-0153 citations

10.1016/s0140-6736(19)32942-3

Plaster cast versus functional bracing for Achilles tendon rupture: the UKSTAR RCT

Matthew L. Costa, Juul Achten, Susan Wagland, Ioana R. Marian, Mandy Maredza et al. (13 authors)

Health Technology Assessment2020-02-0119 citations

10.3310/hta24080

Cast versus functional brace in the rehabilitation of patients with a rupture of the Achilles tendon: statistical analysis plan for the UK study of tendo Achilles rehabilitation (UK STAR) multi-centre randomised controlled trial

Ioana R. Marian, Matthew L. Costa, Susan Dutton

Trials2019-05-301 citations

10.1186/s13063-019-3380-x

Cast versus functional brace in the rehabilitation of patients treated non-operatively for a rupture of the Achilles tendon: protocol for the UK study of tendo achilles rehabilitation (UK STAR) multi-centre randomised trial

Juul Achten, Nick Parsons, Rebecca Kearney, Michael Maia Schlüssel, Anna S Liew et al. (10 authors)

BMJ Open2017-10-017 citations

10.1136/bmjopen-2017-019628

Interventions

Participants will be randomized 1:1 to the following two groups: 1. A plaster cast will be applied in the ‘gravity equinus’ position. Over the first 8 weeks, as the tendon heals, the position of the p

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients will be considered for participation in this study if: 1. They are aged 16 years or older 2. They have a primary rupture of the Achilles tendon 3. They have decided to have non-operative treatment

Exclusion criteria

Exclusion criteria: Patients will be excluded from participation in this study if they: 1. Present to the treating hospital more than 14 days after the injury 2. There is evidence that the patient would be unable to adhere to trial procedures or complete questionnaires; for example, a history of permanent cognitive impairment

Design outcomes

Primary

Measure	Time frame
The primary outcome measure for this study is the Achilles tendon Total Rupture Score (ATRS). The ATRS is a validated questionnaire which is self-reported (filled out by the patient). It consists of 10 items assessing symptoms and physical activity specifically related to the Achilles tendon. It measures: strength, fatigue, stiffness, pain, activities of daily living, walking on uneven surfaces, walking upstairs or uphill, running, jumping and physical labour. This data will be collected at baseline, 3, 6 and 9 months post-injury.	—

Measure

Time frame

The primary outcome measure for this study is the Achilles tendon Total Rupture Score (ATRS). The ATRS is a validated questionnaire which is self-reported (filled out by the patient). It consists of 10 items assessing symptoms and physical activity specifically related to the Achilles tendon. It measures: strength, fatigue, stiffness, pain, activities of daily living, walking on uneven surfaces, walking upstairs or uphill, running, jumping and physical labour. This data will be collected at baseline, 3, 6 and 9 months post-injury.

—

Secondary

Measure	Time frame
1. EQ-5D; The EQ-5D-5L is a validated, generic health-related quality of life measure consisting of 5 dimensions each with a 5-level answer possibility. 2. Complications; all complications will be recorded, from the medical records at the 8-week review and self-reported by the patient thereafter, including: re-rupture, blood clots/emboli, pressure areas/hindfoot pain, falls and neurological symptoms in the foot.	—

Measure

Time frame

1. EQ-5D; The EQ-5D-5L is a validated, generic health-related quality of life measure consisting of 5 dimensions each with a 5-level answer possibility. 2. Complications; all complications will be recorded, from the medical records at the 8-week review and self-reported by the patient thereafter, including: re-rupture, blood clots/emboli, pressure areas/hindfoot pain, falls and neurological symptoms in the foot.

—

Countries

England, United Kingdom

Outcome results

None listed